The global Immunoassay Market was valued at USD 16.78 billion in 2016 and is projected to reach USD 32.88 billion by 2025, growing at a CAGR of 7.76% from 2017 to 2025.
An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing cases of infections and chronic diseases
1.2 Increasing application of immunoassays in oncology studies and treatment
1.3 Technical progress
1.4 Growth in biotechnology and pharmaceutical R&D
2. Market Restraints
2.1 Low assurance of accuracy in results
2.2 Stringent Govt. regulations and Tax excision by US govt. on medical devices
Market Segmentation:
1. Global Immunoassay Market, by Product and Services:
1.1 Reagents & Kits
1.2 By Type
1.2.1 Enzyme-Linked Immunosorbent Assay (ELISA) Reagents and Kits
1.2.2 Rapid Test Reagents and Kits
1.2.3 Western Blot Reagents and Kits
1.2.4 Elispot Reagents and Kits
1.2.5 RIA Reagents and Kits
1.2.6 PCR Reagents and Kits
1.3 Analyzers
1.3.1 Purchase Mode
1.3.1.1 Reagent Rental Purchase
1.3.1.2 Outright Purchase
1.3.2 By Type
1.3.2.1 Open-Ended Systems
1.3.2.2 Closed-Ended Systems
1.4 Software and Services
2. Global Immunoassay Market, by Technology:
2.1 Enzyme-Linked Immunosorbent Assay (ELISA)
2.1.1 ELISA Market, By Platform
2.1.1.1 Chemiluminescence Immunoassay (CLIA)
2.1.1.2 Fluorescence Immunoassay (FIA)
2.1.1.3 Colorimetric Immunoassay (CI)
2.1.2 ELISA Market, By Type
2.1.2.1 First Generation
2.1.2.2 Second Generation
2.1.2.3 Third Generation
2.1.2.4 Fourth Generation and Above
2.2 Rapid Tests
2.3 Western Blot
2.4 Elispot
2.5 Radioimmunoassay (RIA)
2.6 Polymerase Chain Reaction (PCR)
3. Global Immunoassay Market, by End User:
3.1 Hospitals
3.2 Clinical Laboratories
3.3 Blood Banks
3.4 Research & Academic Laboratories
3.5 Pharmaceutical Companies, Cros, and Biotechnology Companies
3.6 Other End Users
4. Global Immunoassay Market, by Application:
4.1 Infectious Diseases
4.2 Endocrinology
4.3 Bone and Mineral Disorders
4.4 Oncology
4.5 Cardiology
4.6 Hematology and Blood Screening
4.7 Autoimmune Disorders
4.8 Toxicology
4.9 Neonatal Screening
4.10 Other Applications
5. Global Immunoassay Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. F. Hoffmann-La Roche Ltd.
2. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
3. Bio-Rad Laboratories, Inc.
4. Siemens AG
5. Sysmex Corporation
6. Biomerieux Sa
7. Alere Inc.
8. Becton, Dickinson and Company
9. Ortho Clinical Diagnostics, Inc.
10. Abbott Laboratories, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Immunoassay Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL IMMUNOASSAY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL IMMUNOASSAY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL IMMUNOASSAY MARKET, BY PRODUCT AND SERVICES
5.1 Reagents & Kits
5.2 By Type
5.2.1 Enzyme-Linked Immunosorbent Assay (ELISA) Reagents and Kits
5.2.2 Rapid Test Reagents and Kits
5.2.3 Western Blot Reagents and Kits
5.2.4 Elispot Reagents and Kits
5.2.5 RIA Reagents and Kits
5.2.6 PCR Reagents and Kits
5.3 Analyzers
5.3.1 Purchase Mode
5.3.1.1 Reagent Rental Purchase
5.3.1.2 Outright Purchase
5.3.2 By Type
5.3.2.1 Open-Ended Systems
5.3.2.2 Closed-Ended Systems
5.4 Software and Services
6 GLOBAL IMMUNOASSAY MARKET, BY TECHNOLOGY
6.1 Enzyme-Linked Immunosorbent Assay (ELISA)
6.1.1 ELISA Market, By Platform
6.1.1.1 Chemiluminescence Immunoassay (CLIA)
6.1.1.2 Fluorescence Immunoassay (FIA)
6.1.1.3 Colorimetric Immunoassay (CI)
6.1.2 ELISA Market, By Type
6.1.2.1 First Generation
6.1.2.2 Second Generation
6.1.2.3 Third Generation
6.1.2.4 Fourth Generation and Above
6.2 Rapid Tests
6.3 Western Blot
6.4 Elispot
6.5 Radioimmunoassay (RIA)
6.6 Polymerase Chain Reaction (PCR)
7 GLOBAL IMMUNOASSAY MARKET, BY END USER
7.1 Hospitals
7.2 Clinical Laboratories
7.3 Blood Banks
7.4 Research & Academic Laboratories
7.5 Pharmaceutical Companies, Cros, and Biotechnology Companies
7.6 Other End Users
8 GLOBAL IMMUNOASSAY MARKET, BY APPLICATION
8.1 Infectious Diseases
8.2 Endocrinology
8.3 Bone and Mineral Disorders
8.4 Oncology
8.5 Cardiology
8.6 Hematology and Blood Screening
8.7 Autoimmune Disorders
8.8 Toxicology
8.9 Neonatal Screening
8.10 Other Applications
9 GLOBAL IMMUNOASSAY MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL IMMUNOASSAY MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Beckman Coulter, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Siemens AG
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Sysmex Corporation
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Biomerieux Sa
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Alere Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Becton, Dickinson and Company
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Ortho Clinical Diagnostics, Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Abbott Laboratories, Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports